[Axillary lymph node irradiation in breast cancer: state of the art].
Identifieur interne : 002205 ( PubMed/Corpus ); précédent : 002204; suivant : 002206[Axillary lymph node irradiation in breast cancer: state of the art].
Auteurs : Pierre Auberdiac ; Cyrus Chargari ; Lysian Cartier ; Amira Zioueche ; Adrien Mélis ; Guy De Laroche ; Youlia Kirova ; Nicolas MagnéSource :
- Bulletin du cancer [ 1769-6917 ] ; 2012.
English descriptors
- KwdEn :
- Axilla, Breast Neoplasms (pathology), Breast Neoplasms (radiotherapy), Breast Neoplasms (surgery), Female, Humans, Lymph Node Excision (adverse effects), Lymphatic Irradiation (adverse effects), Lymphatic Irradiation (methods), Lymphatic Metastasis, Lymphedema (etiology), Neoplasm Recurrence, Local, Prognosis, Radiotherapy, Adjuvant (methods).
- MESH :
- adverse effects : Lymph Node Excision, Lymphatic Irradiation.
- etiology : Lymphedema.
- methods : Lymphatic Irradiation, Radiotherapy, Adjuvant.
- pathology : Breast Neoplasms.
- radiotherapy : Breast Neoplasms.
- surgery : Breast Neoplasms.
- Axilla, Female, Humans, Lymphatic Metastasis, Neoplasm Recurrence, Local, Prognosis.
Abstract
Place of axillary radiotherapy in the management of patients with breast cancer remains debated. While the prognostic value of axillary lymph node extension has been largely demonstrated, the benefit of axillary treatment is more uncertain. Large clinical trials having demonstrated the benefit of adjuvant radiotherapy in advanced breast cancer comprised large nodal irradiation, including axillary area. Analyzing the true benefit of axillary radiotherapy is rendered difficult by heterogeneity of series, particularly when focusing on the extent of lymph node dissection. Although adjuvant axillary radiotherapy is usually recommended in patients with insufficient lymph node dissection or with bulky axillary involvement, the prognosis in these patients remains poor by metastatic evolution and such strategy exposes to increased toxicity and functional sequels. Further assessments should better define the optimal indications and the true benefit of axillary radiotherapy.
DOI: 10.1684/bdc.2012.1548
PubMed: 22450226
Links to Exploration step
pubmed:22450226Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Axillary lymph node irradiation in breast cancer: state of the art].</title>
<author><name sortKey="Auberdiac, Pierre" sort="Auberdiac, Pierre" uniqKey="Auberdiac P" first="Pierre" last="Auberdiac">Pierre Auberdiac</name>
<affiliation><nlm:affiliation>Institut de cancérologie de la Loire, département de radiothérapie, Saint-Priest-en-Jarez, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chargari, Cyrus" sort="Chargari, Cyrus" uniqKey="Chargari C" first="Cyrus" last="Chargari">Cyrus Chargari</name>
</author>
<author><name sortKey="Cartier, Lysian" sort="Cartier, Lysian" uniqKey="Cartier L" first="Lysian" last="Cartier">Lysian Cartier</name>
</author>
<author><name sortKey="Zioueche, Amira" sort="Zioueche, Amira" uniqKey="Zioueche A" first="Amira" last="Zioueche">Amira Zioueche</name>
</author>
<author><name sortKey="Melis, Adrien" sort="Melis, Adrien" uniqKey="Melis A" first="Adrien" last="Mélis">Adrien Mélis</name>
</author>
<author><name sortKey="De Laroche, Guy" sort="De Laroche, Guy" uniqKey="De Laroche G" first="Guy" last="De Laroche">Guy De Laroche</name>
</author>
<author><name sortKey="Kirova, Youlia" sort="Kirova, Youlia" uniqKey="Kirova Y" first="Youlia" last="Kirova">Youlia Kirova</name>
</author>
<author><name sortKey="Magne, Nicolas" sort="Magne, Nicolas" uniqKey="Magne N" first="Nicolas" last="Magné">Nicolas Magné</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22450226</idno>
<idno type="pmid">22450226</idno>
<idno type="doi">10.1684/bdc.2012.1548</idno>
<idno type="wicri:Area/PubMed/Corpus">002205</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002205</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Axillary lymph node irradiation in breast cancer: state of the art].</title>
<author><name sortKey="Auberdiac, Pierre" sort="Auberdiac, Pierre" uniqKey="Auberdiac P" first="Pierre" last="Auberdiac">Pierre Auberdiac</name>
<affiliation><nlm:affiliation>Institut de cancérologie de la Loire, département de radiothérapie, Saint-Priest-en-Jarez, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chargari, Cyrus" sort="Chargari, Cyrus" uniqKey="Chargari C" first="Cyrus" last="Chargari">Cyrus Chargari</name>
</author>
<author><name sortKey="Cartier, Lysian" sort="Cartier, Lysian" uniqKey="Cartier L" first="Lysian" last="Cartier">Lysian Cartier</name>
</author>
<author><name sortKey="Zioueche, Amira" sort="Zioueche, Amira" uniqKey="Zioueche A" first="Amira" last="Zioueche">Amira Zioueche</name>
</author>
<author><name sortKey="Melis, Adrien" sort="Melis, Adrien" uniqKey="Melis A" first="Adrien" last="Mélis">Adrien Mélis</name>
</author>
<author><name sortKey="De Laroche, Guy" sort="De Laroche, Guy" uniqKey="De Laroche G" first="Guy" last="De Laroche">Guy De Laroche</name>
</author>
<author><name sortKey="Kirova, Youlia" sort="Kirova, Youlia" uniqKey="Kirova Y" first="Youlia" last="Kirova">Youlia Kirova</name>
</author>
<author><name sortKey="Magne, Nicolas" sort="Magne, Nicolas" uniqKey="Magne N" first="Nicolas" last="Magné">Nicolas Magné</name>
</author>
</analytic>
<series><title level="j">Bulletin du cancer</title>
<idno type="eISSN">1769-6917</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Axilla</term>
<term>Breast Neoplasms (pathology)</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Female</term>
<term>Humans</term>
<term>Lymph Node Excision (adverse effects)</term>
<term>Lymphatic Irradiation (adverse effects)</term>
<term>Lymphatic Irradiation (methods)</term>
<term>Lymphatic Metastasis</term>
<term>Lymphedema (etiology)</term>
<term>Neoplasm Recurrence, Local</term>
<term>Prognosis</term>
<term>Radiotherapy, Adjuvant (methods)</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term>
<term>Lymphatic Irradiation</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymphatic Irradiation</term>
<term>Radiotherapy, Adjuvant</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Axilla</term>
<term>Female</term>
<term>Humans</term>
<term>Lymphatic Metastasis</term>
<term>Neoplasm Recurrence, Local</term>
<term>Prognosis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Place of axillary radiotherapy in the management of patients with breast cancer remains debated. While the prognostic value of axillary lymph node extension has been largely demonstrated, the benefit of axillary treatment is more uncertain. Large clinical trials having demonstrated the benefit of adjuvant radiotherapy in advanced breast cancer comprised large nodal irradiation, including axillary area. Analyzing the true benefit of axillary radiotherapy is rendered difficult by heterogeneity of series, particularly when focusing on the extent of lymph node dissection. Although adjuvant axillary radiotherapy is usually recommended in patients with insufficient lymph node dissection or with bulky axillary involvement, the prognosis in these patients remains poor by metastatic evolution and such strategy exposes to increased toxicity and functional sequels. Further assessments should better define the optimal indications and the true benefit of axillary radiotherapy.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22450226</PMID>
<DateCreated><Year>2012</Year>
<Month>04</Month>
<Day>18</Day>
</DateCreated>
<DateCompleted><Year>2012</Year>
<Month>05</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised><Year>2012</Year>
<Month>04</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1769-6917</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>99</Volume>
<Issue>4</Issue>
<PubDate><Year>2012</Year>
<Month>Apr</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Bulletin du cancer</Title>
<ISOAbbreviation>Bull Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>[Axillary lymph node irradiation in breast cancer: state of the art].</ArticleTitle>
<Pagination><MedlinePgn>471-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1684/bdc.2012.1548</ELocationID>
<Abstract><AbstractText>Place of axillary radiotherapy in the management of patients with breast cancer remains debated. While the prognostic value of axillary lymph node extension has been largely demonstrated, the benefit of axillary treatment is more uncertain. Large clinical trials having demonstrated the benefit of adjuvant radiotherapy in advanced breast cancer comprised large nodal irradiation, including axillary area. Analyzing the true benefit of axillary radiotherapy is rendered difficult by heterogeneity of series, particularly when focusing on the extent of lymph node dissection. Although adjuvant axillary radiotherapy is usually recommended in patients with insufficient lymph node dissection or with bulky axillary involvement, the prognosis in these patients remains poor by metastatic evolution and such strategy exposes to increased toxicity and functional sequels. Further assessments should better define the optimal indications and the true benefit of axillary radiotherapy.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Auberdiac</LastName>
<ForeName>Pierre</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Institut de cancérologie de la Loire, département de radiothérapie, Saint-Priest-en-Jarez, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chargari</LastName>
<ForeName>Cyrus</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cartier</LastName>
<ForeName>Lysian</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zioueche</LastName>
<ForeName>Amira</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mélis</LastName>
<ForeName>Adrien</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>de Laroche</LastName>
<ForeName>Guy</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kirova</LastName>
<ForeName>Youlia</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Magné</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Radiothérapie du creux axillaire dans les cancers du sein : état des lieux.</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Bull Cancer</MedlineTA>
<NlmUniqueID>0072416</NlmUniqueID>
<ISSNLinking>0007-4551</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015182" MajorTopicYN="N">Lymphatic Irradiation</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018714" MajorTopicYN="N">Radiotherapy, Adjuvant</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>3</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>3</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>5</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">22450226</ArticleId>
<ArticleId IdType="pii">S0007-4551(15)30464-1</ArticleId>
<ArticleId IdType="doi">10.1684/bdc.2012.1548</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002205 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002205 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:22450226 |texte= [Axillary lymph node irradiation in breast cancer: state of the art]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:22450226" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |